Richard B. Bartram
2018
In 2018, Richard B. Bartram earned a total compensation of $2.5M as Chief Financial Officer at Esperion Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $90,000 |
|---|---|
| Option Awards | $2,110,673 |
| Salary | $330,000 |
| Other | $9,250 |
| Total | $2,539,923 |
Bartram received $2.1M in option awards, accounting for 83% of the total pay in 2018.
Bartram also received $90K in non-equity incentive plan, $330K in salary and $9.3K in other compensation.
Rankings
In 2018, Richard B. Bartram's compensation ranked 4,597th out of 14,244 executives tracked by ExecPay. In other words, Bartram earned more than 67.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,597 out of 14,244 | 68th |
Division Manufacturing | 1,721 out of 5,759 | 70th |
Major group Chemicals And Allied Products | 619 out of 2,122 | 71st |
Industry group Drugs | 518 out of 1,811 | 71st |
Industry Pharmaceutical Preparations | 400 out of 1,385 | 71st |
Pay ratio
| Richard B. Bartram's Pay | $2,539,923 |
|---|---|
| Median Employee's Pay | $601,814 |
| Pay Ratio | 4to 1 |
In 2018, the annual total compensation of Richard B. Bartram was $2,539,923.
The annual total compensation of the median employee at Esperion Therapeutics was $601,814.
The ratio of Richard B. Bartram's pay to the pay of median employee was therefore 4 to one.
Source: SEC filing on April 18, 2019.
Bartram's colleagues
We found three more compensation records of executives who worked with Richard B. Bartram at Esperion Therapeutics in 2018.